Share
Lab on a chip and Microarrays Market: By Type (Lab-On-A-Chip and Microarrays), By Technology (DNA Microarrays, Microfluidics, Tissue Biochip and Others), By Application (Clinical Diagnostics, Drug Discovery, Genomics and Proteomics and Other Applications) And Region - Global Analysis of Market Size, Share & Trends For 2019-2020 And Forecasts To 2031
Global Lab on a chip and Microarrays was valued at 14.8 billion in 2021 at a CAGR of 19.1%.
A biochip is a device that combines one or more laboratory operations into a single chip, allowing for high-throughput screening & automation. Nanotechnology advancements had led to the increment of lab-on-a-chip technologies. In a few millimeters to a few squares’ centimeter sized device, lab-on-a-chip can incorporate multiple laboratory functions. A biochip device is used to conduct studies on a small scale, allowing for high-throughput automation & screening. Protein arrays dominated the overall marketplace due to their widespread use in proteomics to better understand the human proteomics, drug discovery, diagnostics, and personalized medicine.
Global Lab on a chip and Microarrays market is expected to project a notable CAGR of 19.1% in 2031.
Global Lab on a chip and Microarrays was valued at 14.8 billion in 2021 at a CAGR of 19.1%. The growing demands for point-of-care testing, increasing prevalence of chronic diseases, and expanding application of genomics and proteomics in cancer research are the primary factors driving the overall market.
Lab-on-a-chip segment to grow with the highest CAGR during 2021-31
The Lab-on-a-chip & Microarrays (Biochip) Industry is Fragmented into Types as Lab-On-A-Chip and Microarrays. Due to the growing worldwide population and technological improvements, lab-on-a-chip segment is predicted to grow at a healthy rate. Personalized medicine is becoming more popular, and lab-on-chip technology is becoming more widely available, which will increase demand for it around the world. Through micro fluidic chips, which can handle minute sample volumes, the lab-on-a-chip concept aims to miniaturize laboratory techniques to allow automated and parallelization. These gadgets save a huge amount of time, chemicals are examined as samples right where they're made. Furthermore, the industry has seen frequent advancements in immunoassays based on lab-on-a-chip (LOC) platforms.
DNA microarrays segment to grow with the highest CAGR during 2021-31
DNA Microarrays, Micro fluidics, Tissue Biochip and Others are the several types of lab-on-a-chip. During the forecast period, the DNA microarrays technique type is expected to lead the worldwide lab on a chip market. Furthermore, the growth in the numbers of people with cancer is driving up market demand. Protein arrays dominated the overall marketplace due to their widespread use in proteomics to better understand the human proteomics, drug discovery, diagnostics, and personalized medicine. Due to the increased demand for tailored medications, target therapies, and cancer research and development, DNA microarrays are expected to grow at the highest rate.
Market DynamicsIncreased use of biochips in proteomics
Biochips are becoming more and more popular in biomedical & biotechnological research. The use of biochips in proteomic, such as microarrays, has increased as technology has advanced. Protein biochips have several advantages, including reduced sample consumption and a proclivity for downsizing. Microarray features are crucial for proteome-wide investigation. Proteomics is rapidly being employed in the development of biomarkers and medicines. Furthermore, there is an increase in demand for personalized medicine, which is adding to the market's growth.
Rising developments in simulation studies
Some of the application areas of LoC advanced technologies in the biomedicine include immunoassay LoC for microbe’s detection, real-time PCR sensing chips, DNA chip, genotype chip, cellular analyses chip, as well as cytometry LoC (for HIV), as the Line-On-A-Chip method result in less energy usage and faster synthesis of the outcomes, paving the way for quicker clinical translation and aiding the growth of the lab-on-a-chip market. Recent developments in simulation studies have made it possible to synthesis inorganic nanoparticles for Nano biotechnology in a single construct utilizing LOC technologies, which is excellent for theragnostic applications.
High deployment Cost
The initial increased buying rate and lack of understanding concerning the use of lab-on-a-chip(LOC) and microarrays gadgets in middle-income nations are two major constraining factors that are limiting the lab-on-a-chip market's growth.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global Lab on a chip and Microarrays market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The global lab-on-a-chip industry is dominated by North America. The number of TV & salmonella cases is on the rise, as per the Center of Disease Control and Prevention. As a result, North America's lab-on-a-chip business has expanded to be the largest market region.
Impact of Covid-19 on Lab on a chip and Microarrays MarketThe COVID-19 pandemic has had a significant influence on the global economy. As the virus spread across different nations, many businesses were forced to close and thousands of people quit their jobs. The virus predominantly affected small businesses, but it had an impact on large firms as well. The sudden emergence of the COVID-19 outbreak prompted the establishment of strict lockdown laws in some countries, causing delays in the import and export of Lab-on-a-chip & Microarrays (BIOCHIP).
|
Report Attribute |
Details |
|
Market size value in 2021 |
14.8 billion |
|
Revenue forecast in 2031 |
85.1 billion |
|
Growth Rate |
CAGR of 19.1% from 2021 to 2031 |
|
Base year for estimation |
2020 |
|
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2031 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Type, Technology, Application, and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled |
Becton, Dickinson and Company, Agilent Technologies Inc., Danaher Corporation, Bio-Rad laboratories, Abbott Laboratories, Hoffmann-La Roche Ag, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., and Other Prominent Players. |
Global Lab on a chip and Microarrays was valued at 14.8 billion in 2021 at a CAGR of 19.1%.
A biochip is a device that combines one or more laboratory operations into a single chip, allowing for high-throughput screening & automation. Nanotechnology advancements had led to the increment of lab-on-a-chip technologies.
Lab-On-A-Chip and DNA Microarrays accounted for the largest Lab on a chip and Microarrays market share.
Key players: Becton, Dickinson and Company, Agilent Technologies Inc., Danaher Corporation, Bio-Rad laboratories, Abbott Laboratories, Hoffman-La Roche Ag, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., Cepheid Inc. and Biacore AB.
The market is being driven by the Increased use of biochips in proteomics and Rising developments in simulation studies
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
